使用免疫检查点分子向重组树突细胞的前列腺癌治疗
Se Young Choi1, Yunlim Kim2,3, Bumjin Lim3
1Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Investigative and clinical urology
|May 7, 2024
概括
这项研究表明,抑制树突细胞 (DCs) 中的编程死亡联体1 (PD-L1) 增强了对前列腺癌的抗瘤免疫力. 在DC中抑制PD-L1显著降低瘤生长,并增强T细胞反应.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 前列腺癌仍然是一个重大的健康挑战,特别是抵抗割的形式.
- 树突细胞 (DCs) 对于启动抗瘤免疫反应至关重要.
- 免疫检查点,如PD-L1,可以被利用来增强癌症免疫疗法.
研究的目的:
- 开发针对免疫检查点的重组树突细胞 (DC).
- 评估这些修改后的DCs对前列腺癌的抗瘤疗效和免疫反应.
主要方法:
- 状细胞 (DCs) 是从小鼠骨髓生成的.
- 编程死亡连接体1 (PD-L1) 在DC中使用siRNA被击倒.
- 流细胞计分析了DC表型.
- 在前列腺癌小鼠模型中评估治疗疗效.
- 通过混合的淋巴细胞反应来评估DC功能.
主要成果:
- 用siRNA PD-L1 DCs治疗的小鼠显示瘤体积减少和亡增加.
- 这种治疗显著增加了干扰素和互白素-2的产生.
- 抑制PD-L1基因增强了T细胞的增殖和细胞因子的产生.
结论:
- 单细胞衍生的DCs被PD-L1 siRNA.成功转染.
- 在DC中抑制PD-L1可以放大抗原特异性免疫反应.
- 这种方法支持免疫疗法策略,用于割抵抗性前列腺癌.
相关概念视频
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Cancer Vaccines
358
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
358
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


